# Case 009: Guideline Currency Verification

**Module Demonstrated:** Guideline Currency Check (GCC-v2.1)  
**Scenario:** Detecting and correcting outdated clinical guideline references

---

## Clinical Scenario

A physician is developing a treatment protocol for sepsis and references the 2016 Surviving Sepsis Campaign guidelines. Medical Engine checks if more current guidance exists.

### Query to Medical Engine

```
For sepsis management, I'm following the Surviving Sepsis Campaign 
guidelines from 2016. The key targets are:
- CVP 8-12 mmHg
- MAP â‰¥65 mmHg
- Urine output â‰¥0.5 mL/kg/hr
- ScvO2 â‰¥70%

Is this protocol current?
```

---

## Medical Engine v2.6 Processing

### GCC Module Activation

```
GUIDELINE CURRENCY CHECK INITIATED
â”œâ”€ Guideline: Surviving Sepsis Campaign 2016
â”œâ”€ Age: 9 years
â”œâ”€ Status: OUTDATED â€” major updates available
â”œâ”€ Current version: SSC 2021
```

---

## Medical Engine Response

```
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“‹ MEDICAL ENGINE v2.5 â€” GUIDELINE CURRENCY CHECK
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

REFERENCED GUIDELINE: Surviving Sepsis Campaign 2016
QUERY: Protocol currency verification

CONFIDENCE: HIGH
EVIDENCE LEVEL: I (Society guidelines)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âš ï¸ GUIDELINE OUTDATED â€” UPDATE REQUIRED
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

YOUR REFERENCE: Surviving Sepsis Campaign 2016
â”œâ”€ Published: January 2017 (Crit Care Med)
â”œâ”€ Age: 9 years
â”œâ”€ Status: SUPERSEDED

CURRENT VERSION: Surviving Sepsis Campaign 2021
â”œâ”€ Published: October 2021 (Intensive Care Med & Crit Care Med)
â”œâ”€ PMID: 34599691
â”œâ”€ Age: 4 years
â””â”€ Status: CURRENT STANDARD

ADDITIONAL UPDATE: SSC Sepsis Bundle Update 2023
â”œâ”€ Published: 2023
â”œâ”€ Contains: Performance improvement updates
â””â”€ Status: CURRENT SUPPLEMENT

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ”„ KEY CHANGES: 2016 â†’ 2021
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

YOUR 2016 PROTOCOL VS. CURRENT 2021 RECOMMENDATIONS:

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
1. CVP TARGETING â€” REMOVED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

2016 (YOUR PROTOCOL):
â”œâ”€ Target CVP 8-12 mmHg
â””â”€ Used to guide fluid resuscitation

2021 (CURRENT):
â”œâ”€ CVP targeting NO LONGER RECOMMENDED
â”œâ”€ CVP is poor predictor of fluid responsiveness
â”œâ”€ Use dynamic measures instead:
â”‚   â”œâ”€ Passive leg raise test
â”‚   â”œâ”€ Pulse pressure variation
â”‚   â”œâ”€ Stroke volume variation
â”‚   â””â”€ Fluid challenge assessment
â””â”€ Reference: SSC 2021, Recommendation 21 (weak, low quality)

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
2. ScvO2 â‰¥70% â€” REMOVED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

2016 (YOUR PROTOCOL):
â”œâ”€ Target ScvO2 â‰¥70%
â””â”€ Part of EGDT bundle

2021 (CURRENT):
â”œâ”€ Routine ScvO2 monitoring NOT recommended
â”œâ”€ EGDT trials (ProCESS, ARISE, ProMISe) showed no benefit
â”œâ”€ Focus instead on:
â”‚   â”œâ”€ Lactate clearance
â”‚   â”œâ”€ Clinical perfusion markers
â”‚   â””â”€ Capillary refill time
â””â”€ Reference: SSC 2021, section on hemodynamic monitoring

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
3. FLUID RESUSCITATION â€” UPDATED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

2016 (YOUR PROTOCOL):
â”œâ”€ 30 mL/kg crystalloid within 3 hours
â””â”€ Fixed target for all patients

2021 (CURRENT):
â”œâ”€ 30 mL/kg remains initial target
â”œâ”€ BUT: Individualized assessment afterward
â”œâ”€ Avoid fluid overload (associated with harm)
â”œâ”€ Reassess with dynamic measures
â”œâ”€ Balanced crystalloids preferred over saline (weak)
â””â”€ Reference: SSC 2021, Recommendations 17-20

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
4. VASOPRESSORS â€” UPDATED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

2016 (YOUR PROTOCOL):
â”œâ”€ Norepinephrine first-line
â”œâ”€ Add vasopressin for refractory shock

2021 (CURRENT):
â”œâ”€ Norepinephrine remains first-line (strong)
â”œâ”€ Vasopressin as second agent (adding to NE, not replacing)
â”œâ”€ Consider adding vasopressin when NE 0.25-0.5 mcg/kg/min
â”œâ”€ Dopamine NOT recommended except bradycardia
â””â”€ Reference: SSC 2021, Recommendations 24-28

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
5. CORTICOSTEROIDS â€” CLARIFIED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

2016:
â”œâ”€ Steroids if fluids and vasopressors don't restore stability

2021 (CURRENT):
â”œâ”€ IV corticosteroids suggested for septic shock requiring 
â”‚   ongoing vasopressor therapy
â”œâ”€ Hydrocortisone 200 mg/day (infusion or divided)
â”œâ”€ NOT for sepsis without shock
â””â”€ Reference: SSC 2021, Recommendation 37

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âœ“ WHAT REMAINS THE SAME
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

STILL RECOMMENDED:
âœ“ MAP â‰¥65 mmHg target (strong recommendation)
âœ“ Urine output â‰¥0.5 mL/kg/hr as perfusion marker
âœ“ Lactate measurement and trending
âœ“ Early antibiotics (within 1 hour for septic shock)
âœ“ Source control when appropriate
âœ“ Norepinephrine as first-line vasopressor

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“‹ UPDATED PROTOCOL SUMMARY
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

HOUR-1 BUNDLE (SSC 2021):
â–¡ Measure lactate, remeasure if elevated
â–¡ Obtain blood cultures before antibiotics
â–¡ Administer broad-spectrum antibiotics
â–¡ Begin 30 mL/kg crystalloid for hypotension or lactate â‰¥4
â–¡ Start vasopressors if hypotensive during/after fluids

HEMODYNAMIC TARGETS:
â”œâ”€ MAP â‰¥65 mmHg
â”œâ”€ Lactate normalization
â”œâ”€ Clinical perfusion improvement
â””â”€ Dynamic fluid responsiveness assessment

REMOVED FROM BUNDLE:
âœ— CVP targeting
âœ— ScvO2 monitoring
âœ— Fixed fluid volumes after initial bolus

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“š CITATIONS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

CURRENT GUIDELINE:
Evans L, et al. Surviving Sepsis Campaign: International 
Guidelines for Management of Sepsis and Septic Shock 2021. 
Intensive Care Med 2021;47:1181-1247. PMID: 34599691
Status: VERIFIED âœ“

SUPPLEMENTAL:
Surviving Sepsis Campaign Research Priorities 2023
Intensive Care Med 2023

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âœ“ RECOMMENDED ACTION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

1. UPDATE your protocol to SSC 2021 standards
2. REMOVE CVP and ScvO2 targeting
3. ADD dynamic fluid assessment measures
4. IMPLEMENT Hour-1 Bundle
5. DOCUMENT protocol revision date

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“ AUDIT TRAIL
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Timestamp: 2025-11-25T19:30:00Z
Module: GCC-v2.1
Guideline checked: SSC 2016
Status: OUTDATED (9 years)
Current version: SSC 2021
Key changes identified: 5 major updates
Citation verified: PMID 34599691 âœ“

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

## Why This Case Matters

### Clinical Guidelines Evolve

- Sepsis management changed significantly from 2016 to 2021
- EGDT components (CVP, ScvO2) were removed based on new evidence
- Using outdated guidelines can lead to suboptimal care

### Medical Engine Protections

1. **Automatic currency detection** - Identifies 9-year-old guideline
2. **Specific change documentation** - Point-by-point comparison
3. **Current citation provided** - Verified PMID for update
4. **Action items** - Clear steps to update protocol

### Without Medical Engine

A physician might:
- Continue using CVP targeting (no longer recommended)
- Target ScvO2 â‰¥70% (not supported by current evidence)
- Miss updates to fluid and vasopressor recommendations

### With Medical Engine

- Outdated guideline immediately flagged
- 5 major changes clearly explained
- What remains unchanged also noted
- Current Hour-1 Bundle provided

---

## Guideline Evolution

| Element | 2016 | 2021 |
|---------|------|------|
| CVP target | 8-12 mmHg | Removed |
| ScvO2 target | â‰¥70% | Removed |
| Fluid assessment | Fixed volumes | Dynamic measures |
| MAP target | â‰¥65 mmHg | â‰¥65 mmHg (unchanged) |
| First-line pressor | Norepinephrine | Norepinephrine (unchanged) |

---

**Case Version:** 1.0  
**Last Updated:** November 2025
